Literature DB >> 18068417

Type I interferon as a stimulus for cross-priming.

Agnès Le Bon1, David F Tough.   

Abstract

Type I interferon (IFN-alpha/beta) is induced rapidly by infection and is well recognised for its crucial role in innate defence. However, it is evident that IFN-alpha/beta also serves as a signal for the generation of adaptive immune responses. In this review, we focus on the involvement of IFN-alpha/beta in the induction of CD8+ T cell responses by cross-priming.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18068417     DOI: 10.1016/j.cytogfr.2007.10.007

Source DB:  PubMed          Journal:  Cytokine Growth Factor Rev        ISSN: 1359-6101            Impact factor:   7.638


  59 in total

1.  Control of type I interferon-induced cell death by Orai1-mediated calcium entry in T cells.

Authors:  Chanyu Yue; Jonathan Soboloff; Ana M Gamero
Journal:  J Biol Chem       Date:  2011-12-05       Impact factor: 5.157

2.  Prolonged antigen storage endows merocytic dendritic cells with enhanced capacity to prime anti-tumor responses in tumor-bearing mice.

Authors:  Rachel A Reboulet; Cassandra M Hennies; Zacarias Garcia; Stefan Nierkens; Edith M Janssen
Journal:  J Immunol       Date:  2010-08-18       Impact factor: 5.422

3.  Mesenchymal stromal cells inhibit murine syngeneic anti-tumor immune responses by attenuating inflammation and reorganizing the tumor microenvironment.

Authors:  Jaime F Modiano; Beth A Lindborg; Ron T McElmurry; Mitzi Lewellen; Colleen L Forster; Edward A Zamora; Jerome Schaack; Donald Bellgrau; Timothy D O'Brien; Jakub Tolar
Journal:  Cancer Immunol Immunother       Date:  2015-08-07       Impact factor: 6.968

4.  Porous silicon microparticle potentiates anti-tumor immunity by enhancing cross-presentation and inducing type I interferon response.

Authors:  Xiaojun Xia; Junhua Mai; Rong Xu; Jorge Enrique Tovar Perez; Maria L Guevara; Qi Shen; Chaofeng Mu; Hui-Ying Tung; David B Corry; Scott E Evans; Xuewu Liu; Mauro Ferrari; Zhiqiang Zhang; Xian Chang Li; Rong-Fu Wang; Haifa Shen
Journal:  Cell Rep       Date:  2015-04-30       Impact factor: 9.423

Review 5.  Cytopathic bovine viral diarrhea viruses (BVDV): emerging pestiviruses doomed to extinction.

Authors:  Ernst Peterhans; Claudia Bachofen; Hanspeter Stalder; Matthias Schweizer
Journal:  Vet Res       Date:  2010-03-04       Impact factor: 3.683

6.  Vesicular stomatitis virus M protein mutant stimulates maturation of Toll-like receptor 7 (TLR7)-positive dendritic cells through TLR-dependent and -independent mechanisms.

Authors:  Maryam Ahmed; Latoya M Mitchell; Shelby Puckett; Kristina L Brzoza-Lewis; Douglas S Lyles; Elizabeth M Hiltbold
Journal:  J Virol       Date:  2009-01-14       Impact factor: 5.103

7.  Role of PKR and Type I IFNs in viral control during primary and secondary infection.

Authors:  Yumi Nakayama; Erin H Plisch; Jeremy Sullivan; Chester Thomas; Charles J Czuprynski; Bryan R G Williams; M Suresh
Journal:  PLoS Pathog       Date:  2010-06-24       Impact factor: 6.823

8.  Innate killing of Leishmania donovani by macrophages of the splenic marginal zone requires IRF-7.

Authors:  Rebecca Phillips; Mattias Svensson; Naveed Aziz; Asher Maroof; Najmeeyah Brown; Lynette Beattie; Nathalie Signoret; Paul M Kaye
Journal:  PLoS Pathog       Date:  2010-03-12       Impact factor: 6.823

9.  Human CD141+ (BDCA-3)+ dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens.

Authors:  Sarah L Jongbloed; Andrew J Kassianos; Kylie J McDonald; Georgina J Clark; Xinsheng Ju; Catherine E Angel; Chun-Jen J Chen; P Rod Dunbar; Robert B Wadley; Varinder Jeet; Annelie J E Vulink; Derek N J Hart; Kristen J Radford
Journal:  J Exp Med       Date:  2010-05-17       Impact factor: 14.307

Review 10.  Immunomodulatory effects of dsRNA and its potential as vaccine adjuvant.

Authors:  Bo Jin; Tao Sun; Xiao-Hong Yu; Chao-Qun Liu; Ying-Xiang Yang; Ping Lu; Shan-Feng Fu; Hui-Bin Qiu; Anthony E T Yeo
Journal:  J Biomed Biotechnol       Date:  2010-07-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.